Queue-Based MAC Protocol with Subcarrier Allocation Optimization
    81.
    发明申请
    Queue-Based MAC Protocol with Subcarrier Allocation Optimization 有权
    基于队列的MAC协议与子载波分配优化

    公开(公告)号:US20170019922A1

    公开(公告)日:2017-01-19

    申请号:US15153748

    申请日:2016-05-13

    Abstract: A MAC protocol, useful for WLANs, is provided for random access over a channel. The protocol includes three concurrent processes. The channel includes a contention subchannel and a transmission subchannel. In the contention process, all nodes use the standard RTS/CTS mechanism operated on the contention subchannel to contend for a transmission right. When one node gains the right, all the nodes store the contention result into their respective contention queue (CQ) buffers. In the transmission process, the nodes sequentially transmit their data over the transmission subchannel according to the order of the nodes stored in the CQ buffers. When one node finishes transmission, the CQ buffers are updated. The contention and transmission processes are connected by the queuing process for dynamically updating each node's CQ buffer. When OFDM is used in a random-access system, numbers of data subcarriers in both subchannels for maximizing the system throughput are given.

    Abstract translation: 提供对WLAN有用的MAC协议,用于通过信道进行随机访问。 协议包括三个并发进程。 信道包括争用子信道和传输子信道。 在争用过程中,所有节点都使用在争用子信道上运行的标准RTS / CTS机制来争取发送权。 当一个节点获得权限时,所有节点将争用结果存储到它们各自的争用队列(CQ)缓冲器中。 在传输过程中,节点根据存储在CQ缓冲器中的节点的顺序,依次通过传输子信道发送它们的数据。 当一个节点完成传输时,更新CQ缓冲区。 争用和传输过程通过排队过程连接,动态更新每个节点的CQ缓冲区。 当在随机接入系统中使用OFDM时,给出用于最大化系统吞吐量的两个子信道中的数据子载波的数目。

    TRANSGENIC MODEL FOR DELAY-TYPE HYPERSENSITIVITY (DTH) AND USE THEREOF
    84.
    发明申请
    TRANSGENIC MODEL FOR DELAY-TYPE HYPERSENSITIVITY (DTH) AND USE THEREOF 有权
    用于延迟型超高频(DTH)的转换模型及其用途

    公开(公告)号:US20160037757A1

    公开(公告)日:2016-02-11

    申请号:US14620141

    申请日:2015-02-11

    Abstract: The present invention provides an in vivo platform for identifying and determining therapeutic or prophylactic activity of test compounds in delay-type hypersensitivity (DTH) and other inflammatory or cancerous diseases mediated by activation of IKK-βC46A mutants. The in vivo platform of the present invention is a non-human transgenic mammal, e.g., a mouse model, with a site directed mutagenesis at a cysteine residue replaced by alanine in IKK-β protein kinase. The site directed mutagenesis is introduced by a specially designed targeting vector containing a transversion in exon 3 of the Ikbkb genes encoding the IKK-β. The present invention also provides methods for generating the transgenic mammal and for determining and identifying compounds that can inhibit activation of IKK-βC46A mutants.

    Abstract translation: 本发明提供了一种用于鉴定和确定延迟型超敏反应(DTH)和通过IKK-和bgr C46A突变体的活化介导的其它炎性或癌性疾病的测试化合物的治疗或预防活性的体内平台。 本发明的体内平台是非人转基因哺乳动物,例如小鼠模型,在IKK-和bgr中被半胱氨酸残基替换为丙氨酸的位点定向诱变; 蛋白激酶。 通过特异设计的靶向载体引入定点诱变,所述靶向载体在编码IKK-&bgr的Ikbkb基因的外显子3中含有颠换。 本发明还提供了产生转基因哺乳动物以及用于测定和鉴定可以抑制IKK-Bgr C46A突变体活化的化合物的方法。

    Location management utilizing initial position for mobile networks
    85.
    发明授权
    Location management utilizing initial position for mobile networks 有权
    利用移动网络初始位置进行位置管理

    公开(公告)号:US09232351B1

    公开(公告)日:2016-01-05

    申请号:US14658227

    申请日:2015-03-15

    Inventor: Qinglin Zhao

    CPC classification number: H04W4/02 H04W4/021 H04W60/04 H04W64/003 H04W68/005

    Abstract: The present invention provides a method for updating a mobile terminal (MT) for a mobile communication network when the MT crosses a boundary of a first location-update (LA) area. The method comprises determining a second LA to be assigned to the MT for replacing the first LA. The second LA is characterized by a LA center and a LA size, both determined by optimizing them in a sense that a mean total location-management cost is minimized without restricting the LA center to be fixed at the initial position. The initial position is defined as the location where the MT performs a latest location update at the first LA before crossing the boundary. This invention also provides schemes of partitioning the second LA into sub-paging areas for use in paging the MT when a call arrives at the network, so as to minimize the paging cost while satisfying delay requirements.

    Abstract translation: 本发明提供一种当MT越过第一位置更新(LA)区域的边界时,为移动通信网络更新移动终端(MT)的方法。 该方法包括确定要分配给MT以用于替换第一LA的第二LA。 第二个LA的特征在于LA中心和LA大小,两者都通过优化它们来确定,即在平均总位置管理成本最小化的意义上,而不将LA中心限制在初始位置。 初始位置被定义为MT在穿过边界之前在第一LA处执行最新位置更新的位置。 本发明还提供了当呼叫到达网络时将第二LA划分为子寻呼区域以用于寻呼MT的方案,以便在满足延迟要求的同时最小化寻呼成本。

    Method for scheduling single-arm cluster tools with wafer revisiting and residency time constraints
    86.
    发明授权
    Method for scheduling single-arm cluster tools with wafer revisiting and residency time constraints 有权
    用于调整具有晶片重新访问和驻留时间约束的单臂集群工具的方法

    公开(公告)号:US09223307B1

    公开(公告)日:2015-12-29

    申请号:US14639980

    申请日:2015-03-05

    Abstract: In semiconductor manufacturing, there are wafer fabrication processes in cluster tools that need a wafer to visit some processing steps for more than once, leading to a revisiting process. Also, wafers may be subject to wafer residency time constraints. By considering atomic layer deposition (ALD) as a typical wafer revisiting process, this invention studies the challenging scheduling problem of single-arm cluster tools for the ALD process with wafer residency time constraints. By recognizing that the key to this problem is to schedule the robot tasks, the present invention presents different robot task sequencing strategies. With these strategies for different cases, the present invention performs the schedulability analysis and derives the schedulability conditions for such tools for the first time. If schedulable, the present invention proposes scheduling algorithms to obtain an optimal schedule efficiently. Illustrative examples are given to show the application of the proposed concepts and approach.

    Abstract translation: 在半导体制造中,在集群工具中存在晶片制造工艺,其需要晶片多次访问一些处理步骤,导致重新审视过程。 此外,晶片可能受到晶片驻留时间限制。 通过考虑原子层沉积(ALD)作为典型的晶片再访问过程,本发明研究了具有晶圆驻留时间约束的ALD工艺的单臂簇工具的具有挑战性的调度问题。 通过认识到这个问题的关键是计划机器人任务,本发明提出了不同的机器人任务排序策略。 利用这些针对不同情况的策略,本发明首次执行可调度性分析并得出这些工具的可调度条件。 如果可调度,本发明提出调度算法以有效地获得最佳调度。 给出说明性的例子来说明所提出的概念和方法的应用。

    Method for predicting and detecting network intrusion in a computer network
    88.
    发明授权
    Method for predicting and detecting network intrusion in a computer network 有权
    在计算机网络中预测和检测网络入侵的方法

    公开(公告)号:US09148439B2

    公开(公告)日:2015-09-29

    申请号:US14201942

    申请日:2014-03-10

    Abstract: A method of detecting an internet attack against a computing device is disclosed. The method of detecting an internet attack against a computing device comprising the steps of receiving a plurality of incoming network packets; extracting a plurality of incoming feature packets based on the plurality of incoming network packets; predicting a predicted incoming feature packet based on the plurality of incoming feature packets; obtaining a first classification data based on one of the incoming feature packets using a first classifier; obtaining a second classification data based on the predicted incoming feature packet by using a second classifier; and performing at least one remedy action if the first classification data or the second classification data identifies the internet intrusion attack; wherein each of the plurality of incoming feature packets and the predicted incoming feature packet comprise a plurality of incoming features and a plurality of predicted features respectively.

    Abstract translation: 公开了一种检测针对计算设备的因特网攻击的方法。 一种检测针对计算设备的因特网攻击的方法,包括以下步骤:接收多个传入网络分组; 基于所述多个传入网络分组来提取多个输入特征分组; 基于所述多个输入特征分组来预测预测的进入特征分组; 使用第一分类器基于所述输入特征分组之一获得第一分类数据; 通过使用第二分类器基于预测的进入特征分组获得第二分类数据; 以及如果所述第一分类数据或所述第二分类数据识别所述互联网入侵攻击,则执行至少一种补救措施; 其中所述多个输入特征分组和所述预测输入特征分组中的每一个分别包括多个输入特征和多个预测特征。

    Nucleic acid molecules and uses thereof

    公开(公告)号:US11866704B2

    公开(公告)日:2024-01-09

    申请号:US17247265

    申请日:2020-12-06

    CPC classification number: C12N15/113 C12N2310/14 C12N2310/32

    Abstract: A method of treating a subject suffering from cancer comprising a step of administering an effective amount of a group of double-stranded RNA molecules to the subject, wherein the RNA molecule is isolated or derived from a bacteria of the genus Escherichia. A method of inhibiting growth or proliferation of cancer cells comprising a step of contacting said cells with said RNA molecule; and a pharmaceutical composition for treating cancer comprising said RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector comprising the double-stranded RNA molecule.

Patent Agency Ranking